Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanoparticle polymeric micellar paclitaxel plus gemcitabine for first-line metastatic pancreatic cancer
ChiCTR2300078861Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paclitaxel and gemcitabine in pancreatic cancer (PC), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: progression-free survival. Started Dec 2023; status: recruiting.
02
Drugs
paclitaxelgemcitabine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on ChiCTR2300078861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078861.